What AI says about Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund invests in pioneering science to develop first-in-class, disease-modifying therapeutics across multiple modalities. The fund has invested in 70 companies and fund-in-fund opportunities globally, leveraging its team's deep pharmaceutical R&D expertise.
AI named Boehringer Ingelheim Venture Fund in January 2026.
